بدائل البحث:
ns decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), use decreased (توسيع البحث)
nn decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), mean decrease (توسيع البحث)
we decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), mean decrease (توسيع البحث)
1 decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), _ decreased (توسيع البحث)
01 1 » 1 1 (توسيع البحث), 0 1 (توسيع البحث)
ns decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), use decreased (توسيع البحث)
nn decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), mean decrease (توسيع البحث)
we decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), mean decrease (توسيع البحث)
1 decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), _ decreased (توسيع البحث)
01 1 » 1 1 (توسيع البحث), 0 1 (توسيع البحث)
-
241
-
242
-
243
-
244
Discovery of New Inhibitors of Hepatitis C Virus NS3/4A Protease and Its D168A Mutant
منشور في 2019"…Several drugs targeting the protease have been developed, but drug-resistant mutant strains emerged. Here, we screened a library and synthesized a novel class of small molecules based on a tryptophan derivative scaffold identified as HCV NS3/4A protease inhibitors that are active against both wild type and mutant form of the protease. …"
-
245
-
246
-
247
Loss of <i>Nf1</i> increases sleep fragmentation and decreases sleep depth.
منشور في 2023"…Compared to controls, pan-neuronal knockdown of <i>Nf1</i> has mixed effects on arousal threshold during the day (nsyb/+, <i>P</i><0.2138; <i>Nf1</i><sup>RNAi</sup>/+, <i>P</i><0.0040) and significantly decreases arousal threshold during the night (nsyb/+, <i>P</i><0.0271; <i>Nf1</i><sup>RNAi</sup>/+, <i>P</i><0.00062). …"
-
248
-
249
-
250
-
251
-
252
-
253
-
254
-
255
S1 Data -
منشور في 2025"…Additionally, mice in the PRE and POS groups showed significantly increased levels of IL-10 (<i>P</i> < 0.01), and significantly decreased levels of IL-5, IL-13, MCP-1, eotaxin, and tumor necrosis factor-α (<i>P</i> < 0.01).…"
-
256
-
257
-
258
-
259
-
260
Identification, Synthesis, and Biological Evaluations of Potent Inhibitors Targeting Type I Protein Arginine Methyltransferases
منشور في 2022"…CARM1 (coactivator-associated arginine methyltransferase 1), which belongs to type I PRMTs (protein arginine methyltransferases), is a potential therapeutic target for treatment of multiple cancers. In this study, we first identified several hit compounds against CARM1 by structure-based virtual screening (IC<sub>50</sub> = 35.51 ± 6.68 to 68.70 ± 8.12 μM) and then carried out chemical structural optimizations, leading to six compounds with significantly improved activities targeting CARM1 (IC<sub>50</sub> = 18 ± 2 to 107 ± 6 nM). …"